Albany, New York, May 31, 2017: Market Research Hub’s Pharmaceutical and Healthcare latest pipeline guide Oropharyngeal Cancer – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1070436
Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. The oropharynx is a middle part of the throat which includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types, HPV-positive, which are related to human papillomavirus infection, and HPV-negative cancers, which are usually linked to alcohol or tobacco use.
The Oropharyngeal Cancer (Oncology) pipeline guide also reviews key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers Therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 4, 6 and 4 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.
Oropharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope:
– The pipeline guide provides a snapshot of the global therapeutic landscape of Oropharyngeal Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Oropharyngeal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Oropharyngeal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Oropharyngeal Cancer (Oncology) therapeutics based on the mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews the latest news related to pipeline therapeutics for Oropharyngeal Cancer (Oncology)
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/head-and-neck-cancer-pipeline-review-h1-2017-report.html
Reasons to Buy:
The Oropharyngeal Cancer (Oncology) pipeline guide also reviews key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers Therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 4, 6 and 4 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.
Oropharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Table of Contents:
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Oropharyngeal Cancer – Overview
Oropharyngeal Cancer – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Oropharyngeal Cancer – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Oropharyngeal Cancer – Companies Involved in Therapeutics Development
Advaxis Inc
AstraZeneca Plc
Cell Medica Ltd
Celldex Therapeutics Inc
Immunovaccine Inc
ISA Pharmaceuticals BV
Merck & Co Inc
Pfizer Inc
PNP Therapeutics Inc
Tessa Therapeutics Pte Ltd
Oropharyngeal Cancer – Drug Profiles
axalimogene filolisbac – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BMX-001 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CDX-3379 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/